期刊文献+

类风湿关节炎病人血清Th_1/Th_2细胞因子的水平及临床意义

THE LEVEL AND CLINICAL SIGNIFICATION OF THE SERUM TH_1/TH_2 CYTOKINE IN PATIENTS WITH RHEUMATOID ARTHRITIS
暂未订购
导出
摘要 目的:探讨类风湿关节炎(rheum atoid arthritis,RA)病人Th1/Th2平衡状态及血清中细胞因子的变化与RA发病机制及疾病发生发展的的关系。方法:采用酶联免疫吸附测定(ELISA)检测RA病人和正常人血清中Th1型细胞因子IFN-γ、Th2型细胞因子IL-4的水平变化。结果:(1)RA病人血清中IFN-γ水平明显升高,IL-4水平明显下降,与对照组比较差异具有统计学意义(P<0.05);(2)活动期RA病人血清中IFN-γ、IL-4水平变化与缓解期RA病人比较差异具有统计学意义(P<0.05);(3)缓解期与活动期RA病人比较,各临床参数均有明显改善。结论:在RA血清中Th1/Th2细胞分泌的细胞因子存在明显失衡,分泌模式朝Th1偏移,Th1/Th2平衡可能与RA的发病机制及疾病的发生发展密切相关。 Objective :To analyze the relationship between Th1/Th2 balance, the cytokine in serum and pathogenesis and development of rheumatoid arthritis(R_A). Methods :IFN -γ, IL- 4 in Sera from patients with RA and control subjects, IFN - γ, IL - 4 examined by ELISA. Results: ( 1 ) The level of IFN -γ increased obviously, and IL- 4 reduced obviously which had statistical significance (P 〈 0. 05 ) . (2)The level of IFN -γ and IL -4 between active stage and remission stage had statistical difference (P 〈 0. 05). (3) The clinical parameter of RA in remission stage had more obvious improvement than RA in active stage. Conclusion :There are obviously imbalance in Th1/Th2 cytokines level of serum of patients with RA. Shift of cytokine secreting pattern is partial to Th1. Th1/Th2 balance plays an active role in RA pathogenic mechanism and disease process.
出处 《内蒙古医学院学报》 2007年第6期419-422,共4页 Acta Academiae Medicinae Neimongol
基金 内蒙古自治区自然科学基金(200711020952)
关键词 类风湿关节炎 TH1/TH2细胞因子 rheumatoid arthritis Th1/Th2 eytokine
  • 相关文献

参考文献6

二级参考文献33

  • 1[1]Weaver AL. Differentiating the new rheumatoid arthritis biological therapies. J Clin Rheumatol, 2003, 9:99~114
  • 2[2]Kriegler M, Perez C, DeFay K, et al. A novel form of TNF/calchectin is a cell surface cytotoxic transmembrane protein:ramifications for the complex physiology of TNF. Cell, 1988,53: 45~53
  • 3[3]Lorenz H-M, Antoni C, Valerius T, et al. In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-αantibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. J Immunol, 1996, 156:1646~1653
  • 4[4]Kempeni J. Preliminary results of early clinical trials with the fully human anti-TNFα monoclonal antibody D2E7. Ann Rheum Dis, 1999, 58 (suppl.): S170~S172
  • 5[5]Nishimoto N, Yoshizaki K, Miyasaka N, et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody. Athritis Rheum, 2004, 50 (6): 1761~1769
  • 6[6]Edwards J CW, Szczepanski L, Szechinski, J, et al. Efficacy of B-cell-targeted therapy with Rituximab in patients with rheumatoid arthritis. N Engl J Med, 2004, 350:2572~2581
  • 7[7]Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med, 2001, 344 (1): 76
  • 8[8]Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med, 2001, 344 (3): 240
  • 9[9]Lipsky PE, Van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med, 2000, 343:1594~1602
  • 10[10]Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med, 2002, 346:1349~1356

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部